Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3,230 JPY | +0.94% | 0.00% | +4.53% |
Jun. 10 | Kissei Pharmaceutical Licenses Linzagolix to JW Pharmaceutical for Korean Market | MT |
Jun. 10 | Kissei Pharmaceutical Co., Ltd. Enters into License Agreement with Jw Pharmaceutical Corporation | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.53% | 880M | |
+3.89% | 71.18B | |
+30.13% | 9.61B | |
+28.63% | 4.73B | |
-19.62% | 4.53B | |
+18.41% | 3.68B | |
-36.16% | 2.03B | |
+19.51% | 1.96B | |
-39.38% | 1.81B | |
-45.43% | 1.71B |
- Stock Market
- Equities
- 4547 Stock
- News Kissei Pharmaceutical Co., Ltd.
- Kissei Pharmaceutical's Full-Year Profit Falls 18.5%